Ronald B. Moss
Net Worth
Last updated:
What is Ronald B. Moss net worth?
The estimated net worth of Dr. Ronald B. Moss is at least $3,780,717 as of 18 Mar 2022. He has earned $98,817 from insider trading and has received compensation worth at least $3,681,900 in Adamis Pharmaceuticals Corporation.
What is the salary of Ronald B. Moss?
Dr. Ronald B. Moss salary is $613,650 per year as Chief Medical Officer in Adamis Pharmaceuticals Corporation.
How old is Ronald B. Moss?
Dr. Ronald B. Moss is 64 years old, born in 1961.
What stocks does Ronald B. Moss currently own?
As insider, Dr. Ronald B. Moss owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Adamis Pharmaceuticals Corporation (ADMP) | Chief Medical Officer | 201,911 | $0 | $0 |
What does Adamis Pharmaceuticals Corporation do?
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Ronald B. Moss insider trading
Adamis Pharmaceuticals Corporation
Dr. Ronald B. Moss has made 11 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 8,199 units of ADMP stock worth $4,952 on 18 Mar 2022.
The largest trade he's ever made was exercising 35,553 units of ADMP stock on 1 Dec 2021. As of 18 Mar 2022 he still owns at least 201,911 units of ADMP stock.
Adamis Pharmaceuticals key executives
Adamis Pharmaceuticals Corporation executives and other stock owners filed with the SEC:
- Dr. Dennis J. Carlo (82) Pres, Chief Executive Officer & Director
- Dr. Ronald B. Moss (64) Chief Medical Officer